Knowledge matters and empowers: HPV vaccine advocacy among HPV-related cancer survivors
- 72 Downloads
To describe knowledge about human papillomavirus (HPV), HPV-related care behavior, and advocacy intent (e.g., vaccine recommendation and willingness to become an advocate for vaccination) and to investigate associations between knowledge, HPV-related care behavior, and advocacy intent among HPV-related cancer survivors.
A cross-sectional online survey was offered through Qualtrics to HPV-related cancer survivors who were either volunteers at a cancer center or patients of survivorship clinics.
A total of 200 survivors responded. Only 33.2% of respondents reported knowing their cancer was HPV-related and 56.8% reported HPV vaccine is safe. Participants who knew that their cancer was caused by HPV were more likely to have vaccinated their children (p < .001). Also, participants who knew that the vaccine is safe were more willing to recommend the vaccine (p < .001), to be a peer mentor for others with HPV-related cancers (43.2% vs. 14.0%, p < .001), and to act as an advocate for increasing vaccination rates (44.1% vs. 24.4%, p = 0.01). Finally, survivors who were aware of the vaccine’s effectiveness in decreasing precancerous lesions were more likely to recommend the vaccine (45.7% vs. 12.0%, p = .002).
Raising survivor awareness of the link between HPV and cancer and HPV vaccine safety may increase their willingness to serve as powerful opinion leaders and peer mentors to promote HPV vaccination. Providers may take the simple step of informing patients that their cancer is HPV-related and HPV vaccine is safe to increase the number of informed and empowered survivors.
KeywordsHuman papillomavirus (HPV) Vaccine Oropharyngeal cancer Cervical cancer Survivors Advocacy
Editorial assistance was provided by MD Anderson Cancer Center’s Department of Scientific Publications.
Dr. Ramondetta acknowledges full control of all primary data and will allow journal to review upon request.
This study was supported in part by the National Institutes of Health through MD Anderson’s Cancer Center Support Grant (NCI Grant P30 CA016672) and through generous philanthropic contributions, including a contribution from the Lyda Hill Foundation to The University of Texas MD Anderson Cancer Centers Moon Shots Program. This work is also supported in part by a faculty fellowship from the University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment.
Compliance with ethical standards
The study was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Prevention, C.f.D.C.a. (2017) Cancers associated with human papillomavirus, United States—2010–2014. Atlanta, GAGoogle Scholar
- 3.Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, MacNeil J, Markowitz LE, Singleton JA (2016) National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2015. MMWR Morb Mortal Wkly Rep 65(33):850–858CrossRefGoogle Scholar
- 17.Ladd IG et al (2018) Cervical cancer patients' willingness and ability to serve as health care educators to advocate for human papillomavirus vaccine uptake. J Cancer EducGoogle Scholar
- 18.Simon S (2017) Head and neck cancer survivor advocates for HPV vaccination. In: The American Cancer SocietyGoogle Scholar
- 19.Carter J (2017) Cervical cancer survivor: why I support the HPV vaccine. The University of Texas MD Anderson Cancer Center, Houston, TXGoogle Scholar
- 20.Ryan L (2015) Why I vaccinate my sons against HPV. The University of Texas MD Anderson Cancer Center, Houston, TXGoogle Scholar
- 23.Elizabeth J, Clark P (1996) MSW, Enpowering the cancer survivor, E.L. Stovall, EditorGoogle Scholar
- 24.Mirrielees JA, Breckheimer KR, White TA, Denure DA, Schroeder MM, Gaines ME, Wilke LG, Tevaarwerk AJ (2017) Breast cancer survivor advocacy at a university hospital: development of a peer support program with evaluation by patients, advocates, and clinicians. J Cancer Educ 32(1):97–104CrossRefGoogle Scholar
- 30.Arbyn M et al (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 5:CD009069Google Scholar
- 33.Kaufman J et al (2018) Face-to-face interventions for informing or educating parents about early childhood vaccination. Cochrane Database Syst Rev 5:CD010038Google Scholar
- 34.Center, T.U.o.T.M.A.C. (2018) Squamous cell carcinoma survivor on the importance of the HPV vaccineGoogle Scholar
- 35.Center, T.U.o.T.M.A.C. (2018) Squamous cell carcinoma survivor shares her storyGoogle Scholar
- 36.Center, T.U.o.T.M.A.C. (2018) Cervical cancer patient wishes the HPV vaccine had been available to herGoogle Scholar